Accelerated Stability Studies of Widely Used Pharmaceutical Substances Under Simulated Tropical Conditions
(1986; 119 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documento1. Introduction
Ver el documento2. Index of degradable substances
Ver el documento3. Index of substances resistant to degradation
Cerrar esta carpeta4. Stability experiments on degradable substances
Ver el documentoAcetylsalicylic acid
Ver el documentoAminophylline
Ver el documentoAmitriptyline hydrochloride
Ver el documentoAmmonium chloride
Ver el documentoAmphotericin B
Ver el documentoAmpicillin sodium
Ver el documentoAmpicillin trihydrate
Ver el documentoAntimony sodium tartrate
Ver el documentoAscorbic acid
Ver el documentoBacitracin
Ver el documentoBacitracin zinc
Ver el documentoBenzathine benzylpenicillin
Ver el documentoBenzylpenicillin potassium
Ver el documentoBenzylpenicillin sodium
Ver el documentoBephenium hydroxynaphthoate
Ver el documentoCalcium gluconate
Ver el documentoCalcium para-aminosalicylate
Ver el documentoCarbenicillin sodium
Ver el documentoCefalexin
Ver el documentoChloral hydrate
Ver el documentoChloramphenicol sodium succinate
Ver el documentoChlorphenamine hydrogen maleate
Ver el documentoChlorpromazine hydrochloride
Ver el documentoChlortetracycline hydrochloride
Ver el documentoCloxacillin sodium (monohydrate)
Ver el documentoCoal tar (washed)
Ver el documentoCodeine phosphate
Ver el documentoColecalciferol
Ver el documentoCresol
Ver el documentoDapsone
Ver el documentoDexamethasone sodium phosphate
Ver el documentoDicloxacillin sodium (monohydrate)
Ver el documentoDiethylcarbamazine dihydrogen citrate
Ver el documentoDoxycycline hyclate
Ver el documentoEmetine hydrochloride
Ver el documentoEphedrine
Ver el documentoEphedrine sulfate
Ver el documentoEpinephrine
Ver el documentoEpinephrine hydrogen tartrate
Ver el documentoErgocalciferol
Ver el documentoErgometrine hydrogen maleate
Ver el documentoErgotamine maleate
Ver el documentoErgotamine tartrate
Ver el documentoEthosuximide
Ver el documentoEthylmorphine hydrochloride
Ver el documentoFerrous sulfate
Ver el documentoFluphenazine decanoate
Ver el documentoFluphenazine hydrochloride
Ver el documentoFormaldehyde solution
Ver el documentoGentamicin sulfate
Ver el documentoGuanethidine sulfate
Ver el documentoHexylresorcinol
Ver el documentoHydralazine hydrochloride
Ver el documentoHydrocortisone sodium succinate
Ver el documentoHydroxocobalamin
Ver el documentoHyoscyamine sulfate
Ver el documentoImipramine hydrochloride
Ver el documentoIpecacuanha powder
Ver el documentoIsoprenaline hydrochloride
Ver el documentoIsoprenaline sulfate
Ver el documentoLidocaine hydrochloride
Ver el documentoMelarsoprol
Ver el documentoMercuric oxide yellow
Ver el documentoMetrifonate
Ver el documentoNaloxone hydrochloride
Ver el documentoNeomycin sulfate
Ver el documentoNystatin
Ver el documentoOrciprenaline sulfate
Ver el documentoOxytetracycline hydrochloride
Ver el documentoParomomycin sulfate
Ver el documentoPenicillamine
Ver el documentoPethidine hydrochloride
Ver el documentoPhenobarbital sodium
Ver el documentoPhenoxymethylpenicillin
Ver el documentoPhenoxymethylpenicillin calcium
Ver el documentoPhenoxymethylpenicillin potassium
Ver el documentoPhentolamine mesilate
Ver el documentoPhenylbutazone
Ver el documentoPilocarpine hydrochloride
Ver el documentoPilocarpine nitrate
Ver el documentoProcainamide hydrochloride
Ver el documentoProcaine benzylpenicillin
Ver el documentoProcaine hydrochloride
Ver el documentoProcarbazine hydrochloride
Ver el documentoPromazine hydrochloride
Ver el documentoPromethazine hydrochloride
Ver el documentoPyridoxine hydrochloride
Ver el documentoQuinine bisulfate
Ver el documentoQuinine dihydrochloride
Ver el documentoRetinol (Vitamin A)
Ver el documentoSalbutamol sulfate
Ver el documentoSenna leaf
Ver el documentoSilver nitrate
Ver el documentoSodium calcium edetate
Ver el documentoSodium lactate
Ver el documentoSodium nitrite
Ver el documentoSodium para-aminosalicylate
Ver el documentoSodium stibogluconate
Ver el documentoSulfacetamide sodium
Ver el documentoSulfadiazine sodium
Ver el documentoSulfadimidine sodium
Ver el documentoSuxamethonium chloride
Ver el documentoTetracaine hydrochloride
Ver el documentoTetracycline hydrochloride
Ver el documentoThiamine hydrochloride
Ver el documentoThiamine mononitrate
Ver el documentoThiopental sodium
Ver el documentoTolbutamide
Ver el documentoUndecylenic acid
Ver el documentoWarfarin sodium
 

Codeine phosphate

Accelerated Degradation Experiment

Conditions

Procedure A1:

10 days exposure at 50 °C and 100% relative humidity.

Procedure A2:

20 days exposure at 50 °C and 100% relative humidity.

Procedure A3:

30 days exposure at 50 °C and 100% relative humidity.

Procedure B1:

30 days exposure at 50 °C and 100% relative humidity followed by 4 days at 70 °C and 100% relative humidity.

Procedure B2:

30 days exposure at 50 °C and 100% relative humidity followed by 7 days at 70 °C and 100% relative humidity.

Appearance of the substance

The substance, originally in the form of small colourless crystals or a white, crystalline powder, changes gradually after procedure A into a brown mass and after procedure B into a dark brown liquid.

Gain of moisture

Before exposure to heat and humidity:

5%

After procedure A1:

16%

After procedure A2:

30%

After procedure A3:

42%

After procedure B1:

45%

Chromatographic test

Adsorbent: Silica gel F-254

Solution applied to the plate: Substance dissolved in methanol.

Solvent system:

diethylamine: ..............................1 volume
xylene: ......................................10 volumes
methanol: ....................................3 volumes
ethylmethylketone: ....................10 volumes

Development condition: The solvent is allowed to migrate until the front reaches a line 10 cm from the starting line.

Detection: The plate is examined under ultraviolet light at a wavelength of maximum output at about 254 nm and then left in a chromatographic chamber containing some iodine crystals until spots appear.

Results: The spots obtained from the solution of the sample subjected to procedure A1 and the spots obtained from the reference solution of codeine phosphate display the same chromatographic characteristics. Some secondary spots are observed, one of which is on the starting line. After procedure B1, additional more and less mobile spots than the main spot are revealed, indicating a degradation of about 10%.

High performance liquid chromatography

After procedures A and B: 9% degraded, calculated with reference to the dried substance.

Conclusion

Codeine phosphate is subject to decomposition under accelerated degradation conditions.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012